Christy Kollath-Cattano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christy Kollath-Cattano has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- James Francis Thrasher
University of South Carolina
3 shared publications - Ramzi George Salloum
Health Outcomes and Biomedical Informatics Department, University of Florida, Gainesville, Florida, USA
3 shared publications Allie Kellner
2 shared publications- Andrew W. Albano
PRISMA Health Upstate, Greenville, SC 29605, USA
2 shared publications Anna Kooper
Department of Health and Human Performance, College of Charleston, Charleston, SC 29424, USA
2 shared publicationsJames F Thrasher
Department of Health Promotion, Education, and Behavior, University of South Carolina, Columbia, SC, USA
2 shared publications
Latest Publications
- Open Access
- 1 April 2022
- Published by Annals of Family Medicine
- Vol. 20 (Supplement) , 2924
Smoking cessation counseling decision aid with E-cigarette information: A feasibility test
Context: E-cigarette use has been increasing rapidly, most prominently among adult smokers. Smokers are more likely to use e-cigarettes to help them quit smoking than FDA-recommended methods (e.g., nicotine replacement therapy or prescription medications). Since at least 70% of smokers visit their physician annually, clinical encounters in primary care present a critical opportunity to provide smokers with evidence-based information about e-cigarettes. Objective: Enhance a previously developed prototype decision aid (DA) for smoking cessation counseling in primary care settings incorporating messages based on the behavior change approach of Motivational Interviewing (MI) and conduct focus groups physicians to further refine and inform the design of the enhanced DA. Study Design: Qualitative study. Setting or Dataset: Health system primary care practices. Population studied: Board-certified primary care physicians, PGY2 or 3 residents, nurse practitioners and physician assistants (N=10). Outcome Measures: Develop an enhanced smoking cessation DA incorporating MI-based content. Results: While most participants had formal training in MI techniques during residency, and sometimes used it for smoking cessation counseling, some still found it challenging to engage smokers in discussions about smoking cessation when they did not want to quit (i.e., precontemplation stage). Physicians acknowledged that time constraints and competing priorities (i.e., patient comorbidities) sometimes limited their ability to use MI techniques. Most physicians were familiar with DAs, although prior experience using them in practice was lacking, and only one participant had used them with patients. Physicians in both focus groups expressed interest in using the DA with patients and commented that it had the potential to improve cessation counseling by spending time building off DA content and getting into the “real work” of smoking cessation and employing MI techniques, rather than focusing on “standard” questions that would have already been answered in the DA. Conclusions: An MI-based DA for smoking cessation counseling appears promising for use in primary care settings. Effective implementation will require addressing physician lack of knowledge and experience with using DAs and with discussing e-cigarettes with patients.
- 1 April 2022
- Published by Annals of Family Medicine
- Vol. 20 (Supplement) , 2924
Open AccessSmoking cessation counseling decision aid with E-cigarette information: A feasibility test
Context: E-cigarette use has been increasing rapidly, most prominently among adult smokers. Smokers are more likely to use e-cigarettes to help them quit smoking than FDA-recommended methods (e.g., nicotine replacement therapy or prescription medications). Since at least 70% of smokers visit their physician annually, clinical encounters in primary care present a critical opportunity to provide smokers with evidence-based information about e-cigarettes. Objective: Enhance a previously developed prototype decision aid (DA) for smoking cessation counseling in primary care settings incorporating messages based on the behavior change approach of Motivational Interviewing (MI) and conduct focus groups physicians to further refine and inform the design of the enhanced DA. Study Design: Qualitative study. Setting or Dataset: Health system primary care practices. Population studied: Board-certified primary care physicians, PGY2 or 3 residents, nurse practitioners and physician assistants (N=10). Outcome Measures: Develop an enhanced smoking cessation DA incorporating MI-based content. Results: While most participants had formal training in MI techniques during residency, and sometimes used it for smoking cessation counseling, some still found it challenging to engage smokers in discussions about smoking cessation when they did not want to quit (i.e., precontemplation stage). Physicians acknowledged that time constraints and competing priorities (i.e., patient comorbidities) sometimes limited their ability to use MI techniques. Most physicians were familiar with DAs, although prior experience using them in practice was lacking, and only one participant had used them with patients. Physicians in both focus groups expressed interest in using the DA with patients and commented that it had the potential to improve cessation counseling by spending time building off DA content and getting into the “real work” of smoking cessation and employing MI techniques, rather than focusing on “standard” questions that would have already been answered in the DA. Conclusions: An MI-based DA for smoking cessation counseling appears promising for use in primary care settings. Effective implementation will require addressing physician lack of knowledge and experience with using DAs and with discussing e-cigarettes with patients.
- Open Access
- 1 April 2022
- Published by Annals of Family Medicine
- Vol. 20 (Supplement) , 2888
Feasibility of a primary care patient decision aid for smoking cessation with information about e-cigarettes
Context: Patients who smoke are increasingly using e-cigarettes for smoking cessation. Decision aids can promote the delivery of evidence-based smoking cessation treatment in primary care settings; however, more information is needed on the impact of smoking cessation decision aids which include information on switching completely from cigarettes to e-cigarettes. Objective: To assess the feasibility and acceptability of a smoking cessation decision aid that includes e-cigarette information. Study Design: Pre-post. Setting: Primary care. Population Studied: Adult patients who are current cigarette smokers (N=120). Intervention: In Phase I (N=60), all patients were shown a decision aid with information about FDA-approved cessation methods (i.e., nicotine replacement therapy, prescription medications) prior to their clinic visit. In Phase II (N=60), current smokers who were e-cigarette users and those with no intention of quitting cigarettes received decision aids with additional information on switching to e-cigarettes. Outcome Measures: Quit attempts and abstinence, confidence and readiness to quit, confidence and readiness to switch to e-cigarettes, and patient satisfaction. Results: Patients reported higher confidence and readiness to quit after viewing the decision aid and consulting with their physician across both phases (p<.05). Patients reported the decision aid helped prepare them to make a decision about quitting smoking and expressed satisfaction with the decision aid and physician consultation. There was no impact of including e-cigarette information in the decision aids on any measured outcomes. Conclusions: Smoking cessation decision aids are acceptable to patients and may promote behavior change. Further research is needed to identify strategies to promote shared decision-making regarding e-cigarettes. Future studies should explore the impact of providing patients e-cigarette information using larger sample sizes and rigorous designs.
- 1 April 2022
- Published by Annals of Family Medicine
- Vol. 20 (Supplement) , 2888
Open AccessFeasibility of a primary care patient decision aid for smoking cessation with information about e-cigarettes
Context: Patients who smoke are increasingly using e-cigarettes for smoking cessation. Decision aids can promote the delivery of evidence-based smoking cessation treatment in primary care settings; however, more information is needed on the impact of smoking cessation decision aids which include information on switching completely from cigarettes to e-cigarettes. Objective: To assess the feasibility and acceptability of a smoking cessation decision aid that includes e-cigarette information. Study Design: Pre-post. Setting: Primary care. Population Studied: Adult patients who are current cigarette smokers (N=120). Intervention: In Phase I (N=60), all patients were shown a decision aid with information about FDA-approved cessation methods (i.e., nicotine replacement therapy, prescription medications) prior to their clinic visit. In Phase II (N=60), current smokers who were e-cigarette users and those with no intention of quitting cigarettes received decision aids with additional information on switching to e-cigarettes. Outcome Measures: Quit attempts and abstinence, confidence and readiness to quit, confidence and readiness to switch to e-cigarettes, and patient satisfaction. Results: Patients reported higher confidence and readiness to quit after viewing the decision aid and consulting with their physician across both phases (p<.05). Patients reported the decision aid helped prepare them to make a decision about quitting smoking and expressed satisfaction with the decision aid and physician consultation. There was no impact of including e-cigarette information in the decision aids on any measured outcomes. Conclusions: Smoking cessation decision aids are acceptable to patients and may promote behavior change. Further research is needed to identify strategies to promote shared decision-making regarding e-cigarettes. Future studies should explore the impact of providing patients e-cigarette information using larger sample sizes and rigorous designs.
- 13 May 2021
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 23 (11) , 1880-1888
Evaluation of a Smoking Cessation Patient Decision Aid That Integrates Information About E-Cigarettes
Introduction: Smokers increasingly use e-cigarettes to try to quit smoking, even more than recommended cessation methods. However, few smokers discuss the range of cessation options with their physicians. Decision aids can inform smokers about smoking cessation options, including evidence about e-cigarettes, and encourage smokers to engage in shared decision making with their physician. Aims and Methods: This study aimed to evaluate a smoking cessation decision aid that included e-cigarette risks and benefits. Adult smokers were recruited from primary care clinics for two research phases: (1) usability and acceptability testing of the decision aid (n = 37); and (2) pre-post study that compared usual care (n = 90) with implementation of the decision aid in clinics (n = 90). For the latter, outcome measures included frequency of clinical discussions of readiness to quit, methods to quit in general, and of specific cessation methods, in addition to decisional conflict, communication satisfaction, and overall patient satisfaction. Results: Smokers indicated high usability and acceptability of the decision aid. In the pre-post evaluation, decision aid implementation was associated with higher rates of smokers: being asked if they were ready to quit smoking (89% vs. 67%, respectively; p < .001); discussing methods for smoking cessation in general (81% vs. 48%; p < .001); and discussing specific cessation methods (NRT 55% vs. 26%, p < .001; prescription medications 26% vs. 12%, p = .022). Decision aid use was also associated with higher overall patient satisfaction with the physician visit. Conclusions: Smoking cessation decision aids that incorporate information about e-cigarettes are acceptable among smokers and can lead to evidence-based clinical discussions about smoking cessation. Implications: Smokers use e-cigarettes more than recommended cessation methods when they are trying to quit smoking, yet few physicians discuss the risks and benefits of e-cigarettes with their patients who smoke. This study presents preliminary findings about the feasibility and usability of a clinically based iPad-delivered smoking cessation decision aid that integrates information about e-cigarettes. Although promising, further research with randomized designs, larger samples, and longer-term follow-up is needed to determine whether this type of intervention can effectively promote cessation of all tobacco products and, for those not ready to quit smoking, the use of e-cigarettes for harm reduction.
- 13 May 2021
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 23 (11) , 1880-1888
Evaluation of a Smoking Cessation Patient Decision Aid That Integrates Information About E-Cigarettes
Introduction: Smokers increasingly use e-cigarettes to try to quit smoking, even more than recommended cessation methods. However, few smokers discuss the range of cessation options with their physicians. Decision aids can inform smokers about smoking cessation options, including evidence about e-cigarettes, and encourage smokers to engage in shared decision making with their physician. Aims and Methods: This study aimed to evaluate a smoking cessation decision aid that included e-cigarette risks and benefits. Adult smokers were recruited from primary care clinics for two research phases: (1) usability and acceptability testing of the decision aid (n = 37); and (2) pre-post study that compared usual care (n = 90) with implementation of the decision aid in clinics (n = 90). For the latter, outcome measures included frequency of clinical discussions of readiness to quit, methods to quit in general, and of specific cessation methods, in addition to decisional conflict, communication satisfaction, and overall patient satisfaction. Results: Smokers indicated high usability and acceptability of the decision aid. In the pre-post evaluation, decision aid implementation was associated with higher rates of smokers: being asked if they were ready to quit smoking (89% vs. 67%, respectively; p < .001); discussing methods for smoking cessation in general (81% vs. 48%; p < .001); and discussing specific cessation methods (NRT 55% vs. 26%, p < .001; prescription medications 26% vs. 12%, p = .022). Decision aid use was also associated with higher overall patient satisfaction with the physician visit. Conclusions: Smoking cessation decision aids that incorporate information about e-cigarettes are acceptable among smokers and can lead to evidence-based clinical discussions about smoking cessation. Implications: Smokers use e-cigarettes more than recommended cessation methods when they are trying to quit smoking, yet few physicians discuss the risks and benefits of e-cigarettes with their patients who smoke. This study presents preliminary findings about the feasibility and usability of a clinically based iPad-delivered smoking cessation decision aid that integrates information about e-cigarettes. Although promising, further research with randomized designs, larger samples, and longer-term follow-up is needed to determine whether this type of intervention can effectively promote cessation of all tobacco products and, for those not ready to quit smoking, the use of e-cigarettes for harm reduction.
- 1 June 2020
- Published by Elsevier in Addictive Behaviors
- Vol. 105, 106289
Illicit drug use among college students: The role of social norms and risk perceptions
- 1 June 2020
- Published by Elsevier in Addictive Behaviors
- Vol. 105, 106289
Illicit drug use among college students: The role of social norms and risk perceptions
- 19 February 2019
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 25 (5) , 761-768
E‐cigarettes and the clinical encounter: Physician perspectives on e‐cigarette safety, effectiveness, and patient educational needs
Rationale, aims, and objectives: There is limited research on how health care providers approach the topic of e‐cigarettes in clinical encounters, especially in conjunction with other best‐practice recommendations for smoking cessation. This qualitative study explored physician perceptions and recommendations involving e‐cigarettes in the context of smoking cessation counselling, including their opinions about the implementation and content of patient educational materials that focus on e‐cigarettes.Methods: Semistructured interviews were conducted with 15 physicians from family medicine, internal medicine, and obstetrics/gynaecology (OB/GYN).Results: Physicians did not routinely assess e‐cigarette use among patients and reported that discussions were often initiated by patients. Only a minority of participants discussed e‐cigarettes in conjunction with other best‐practice recommendations for smoking cessation. Most others were more ambivalent about e‐cigarette safety and effectiveness for cessation and did not address the topic, unless patients were already using e‐cigarettes. Almost all, however, agreed that more research on e‐cigarettes was needed. Physicians expressed an interest in having enhanced discussions about e‐cigarettes with their patients and in using patient educational materials to accomplish this. Physicians recommended that these materials not actively promote e‐cigarettes and be tailored to patients based on their demographics and motivation to quit.Conclusions: Physicians were open to improving their smoking cessation counselling and to integrating new patient educational materials that addressed e‐cigarettes. Patient educational materials that provide tailored information about e‐cigarettes could potentially be used initiate e‐cigarette discussions and inform smokers about what is known vs unknown about e‐cigarettes.
- 19 February 2019
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 25 (5) , 761-768
E‐cigarettes and the clinical encounter: Physician perspectives on e‐cigarette safety, effectiveness, and patient educational needs
Rationale, aims, and objectives: There is limited research on how health care providers approach the topic of e‐cigarettes in clinical encounters, especially in conjunction with other best‐practice recommendations for smoking cessation. This qualitative study explored physician perceptions and recommendations involving e‐cigarettes in the context of smoking cessation counselling, including their opinions about the implementation and content of patient educational materials that focus on e‐cigarettes.Methods: Semistructured interviews were conducted with 15 physicians from family medicine, internal medicine, and obstetrics/gynaecology (OB/GYN).Results: Physicians did not routinely assess e‐cigarette use among patients and reported that discussions were often initiated by patients. Only a minority of participants discussed e‐cigarettes in conjunction with other best‐practice recommendations for smoking cessation. Most others were more ambivalent about e‐cigarette safety and effectiveness for cessation and did not address the topic, unless patients were already using e‐cigarettes. Almost all, however, agreed that more research on e‐cigarettes was needed. Physicians expressed an interest in having enhanced discussions about e‐cigarettes with their patients and in using patient educational materials to accomplish this. Physicians recommended that these materials not actively promote e‐cigarettes and be tailored to patients based on their demographics and motivation to quit.Conclusions: Physicians were open to improving their smoking cessation counselling and to integrating new patient educational materials that addressed e‐cigarettes. Patient educational materials that provide tailored information about e‐cigarettes could potentially be used initiate e‐cigarette discussions and inform smokers about what is known vs unknown about e‐cigarettes.
- 8 December 2017
- Published by Taylor & Francis in Addiction Research & Theory
- Vol. 26 (5) , 369-376
‘Everyone wants a community’: a qualitative investigation of the challenges and service needs among college students in recovery
Background: Problem drinking and illicit drug use is prevalent among college students, which can pose challenges for students in recovery from substance use disorders (SUDs). Collegiate recovery programs (CRPs) are emerging across the U.S. in order to provide support services for these students. Yet the population of college students in recovery still remains understudied. The objectives of this research were to explore (1) perceived service needs, and (2) opinions about the logistics of a CRP among a sample of college students in recovery. Methods: Semi-structured interviews were conducted with 13 students who self-identified as being in recovery from SUDs. Interviews were transcribed and coded using content analysis. Results: The sample of students was slightly older than traditional college students (M= 25 years). Due to age and lifestyle differences, such as sobriety, these students often felt isolated and unable to relate to the wider student body. Students also felt limited in their options for recovery support services and they expressed the desire for a formalized on-campus community, such as a CRP. Most stressed that a CRP should have flexibility in program acceptance and maintenance in order to serve all students in need. Conclusions: The results suggest the need to for college campuses, both in the US and abroad, to conduct assessments of the perceived need for recovery support services among students. While substance abuse services may be available, students may not feel they are adequate to support their unique needs as both as a student and in recovery from SUDs.
- 8 December 2017
- Published by Taylor & Francis in Addiction Research & Theory
- Vol. 26 (5) , 369-376
‘Everyone wants a community’: a qualitative investigation of the challenges and service needs among college students in recovery
Background: Problem drinking and illicit drug use is prevalent among college students, which can pose challenges for students in recovery from substance use disorders (SUDs). Collegiate recovery programs (CRPs) are emerging across the U.S. in order to provide support services for these students. Yet the population of college students in recovery still remains understudied. The objectives of this research were to explore (1) perceived service needs, and (2) opinions about the logistics of a CRP among a sample of college students in recovery. Methods: Semi-structured interviews were conducted with 13 students who self-identified as being in recovery from SUDs. Interviews were transcribed and coded using content analysis. Results: The sample of students was slightly older than traditional college students (M= 25 years). Due to age and lifestyle differences, such as sobriety, these students often felt isolated and unable to relate to the wider student body. Students also felt limited in their options for recovery support services and they expressed the desire for a formalized on-campus community, such as a CRP. Most stressed that a CRP should have flexibility in program acceptance and maintenance in order to serve all students in need. Conclusions: The results suggest the need to for college campuses, both in the US and abroad, to conduct assessments of the perceived need for recovery support services among students. While substance abuse services may be available, students may not feel they are adequate to support their unique needs as both as a student and in recovery from SUDs.
- 1 March 2017
- Published by Elsevier in Addictive Behaviors
- Vol. 66, 33-40
Evaluating the perceived effectiveness of pregnancy-related cigarette package health warning labels among different gender/age groups
- 1 March 2017
- Published by Elsevier in Addictive Behaviors
- Vol. 66, 33-40
Evaluating the perceived effectiveness of pregnancy-related cigarette package health warning labels among different gender/age groups
- 1 September 2016
- Published by Elsevier in Preventive Medicine
- Vol. 90, 143-147
Portrayals of character smoking and drinking in Argentine-, Mexican- and US-produced films
- 1 September 2016
- Published by Elsevier in Preventive Medicine
- Vol. 90, 143-147
Portrayals of character smoking and drinking in Argentine-, Mexican- and US-produced films
- Open Access
- 3 November 2015
- Published by Springer Nature in BMC Public Health
- Vol. 15 (1) , 1-7
Comparison of tobacco and alcohol use in films produced in Europe, Latin America, and the United States
Studies that have evaluated tobacco and alcohol portrayals in films have mainly focused on US films. Our aim is to describe tobacco and alcohol portrayals in nationally produced films from six European and two Latin American countries, and compare them with US produced films. A sample of 337 nationally produced and 502 US produced films, consisting of top grossing films from 2004 to 2009 in each country, was content coded for presence of tobacco or alcohol and seconds of tobacco or alcohol use. Logistic and linear regression models were estimated for all films and youth-rated films (Ages 0–14) to assess cross country differences in tobacco and alcohol content, with US films as the reference category. Domestically produced films from several countries were more likely than US films to contain any tobacco use both overall (Iceland (OR = 9.29, CI: 1.22–70.89), Italy (OR = 3.58, CI: 1.72–7.43), Argentina (OR = 5.06, CI: 2.13–12.03), Mexico (OR = 4.87, CI: 2.17–10.90)) and for youth-rated films (Germany (OR = 2.24, CI: 1.21–4.16), Iceland (OR = 13.79, CI: 1.80–105.5), Italy (OR = 5.31, CI: 2.54–11.1), and Argentina (OR = 6.9, CI: 0.88–1.34)). Models for alcohol showed few differences compared to US, regardless of rating. Linear regression models for seconds of use in films with tobacco indicated that only Argentine films had more seconds of smoking than US films, regardless of the rating category. For films with alcohol use, Mexican films had higher seconds of alcohol use than US films. Smoking was more commonly depicted in films produced outside the US, however there were few differences in the means for smoking screen time in films that contained smoking. This may be partly explained by the prohibition of tobacco product placement in the US. Countries should consider banning paid placement of both products and eliminating subsidies for films with content that promotes tobacco and alcohol use.
- 3 November 2015
- Published by Springer Nature in BMC Public Health
- Vol. 15 (1) , 1-7
Open AccessComparison of tobacco and alcohol use in films produced in Europe, Latin America, and the United States
Studies that have evaluated tobacco and alcohol portrayals in films have mainly focused on US films. Our aim is to describe tobacco and alcohol portrayals in nationally produced films from six European and two Latin American countries, and compare them with US produced films. A sample of 337 nationally produced and 502 US produced films, consisting of top grossing films from 2004 to 2009 in each country, was content coded for presence of tobacco or alcohol and seconds of tobacco or alcohol use. Logistic and linear regression models were estimated for all films and youth-rated films (Ages 0–14) to assess cross country differences in tobacco and alcohol content, with US films as the reference category. Domestically produced films from several countries were more likely than US films to contain any tobacco use both overall (Iceland (OR = 9.29, CI: 1.22–70.89), Italy (OR = 3.58, CI: 1.72–7.43), Argentina (OR = 5.06, CI: 2.13–12.03), Mexico (OR = 4.87, CI: 2.17–10.90)) and for youth-rated films (Germany (OR = 2.24, CI: 1.21–4.16), Iceland (OR = 13.79, CI: 1.80–105.5), Italy (OR = 5.31, CI: 2.54–11.1), and Argentina (OR = 6.9, CI: 0.88–1.34)). Models for alcohol showed few differences compared to US, regardless of rating. Linear regression models for seconds of use in films with tobacco indicated that only Argentine films had more seconds of smoking than US films, regardless of the rating category. For films with alcohol use, Mexican films had higher seconds of alcohol use than US films. Smoking was more commonly depicted in films produced outside the US, however there were few differences in the means for smoking screen time in films that contained smoking. This may be partly explained by the prohibition of tobacco product placement in the US. Countries should consider banning paid placement of both products and eliminating subsidies for films with content that promotes tobacco and alcohol use.